Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease
Journal of Materials Chemistry B · 2026 · 14 (13) · 4173-4182
DOI: 10.1039/d5tb02289d ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2026. Verfasst von Chunyan Niu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China. nchy6…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Galactose, Nanoparticles, Sulfonamides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau, LiShui People's Hospital.
Abstract (Originalsprache)
The MCC950-loaded formulation effectively reduced the expression of inflammatory regulators and cytokines associated with the NF-κB/NLRP3-related signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China. nchy69@163.com.
- Department of Endocrinology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China.
- Endoscopy Center, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China. 2389121017@qq.com.
Förderung
- Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau
- LiShui People's Hospital
Zitieren
APA
Niu, C., Gao, W., Tan, M., Chen, Y., Shi, Y., Geng, Y., Tao, H., Xu, Z., Zhang, T., & Yang, J. (2026). Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease. Journal of Materials Chemistry B, 14(13), 4173-4182. https://doi.org/10.1039/d5tb02289d
Vancouver
Niu C, Gao W, Tan M, Chen Y, Shi Y, Geng Y, et al. Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease. Journal of Materials Chemistry B. 2026;14(13):4173-4182. doi:10.1039/d5tb02289d
BibTeX
@article{Niu2026,
author = {Niu, Chunyan and Gao, Wen and Tan, Mei and Chen, Yue and Shi, Yongqiang and Geng, Yan and Tao, Huayi and Xu, Zhenjiang and Zhang, Tingting and Yang, Jinming},
title = {Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease},
journal = {Journal of Materials Chemistry B},
year = {2026},
volume = {14},
number = {13},
pages = {4173--4182},
doi = {10.1039/d5tb02289d}
}
EUVIMED